DECIPHERA
Live / Registered — Registered (as of 21 Sept 2021)
What this means for you
Registered since 21 Sept 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90369273
- Registration number
- 6491847
- Mark type
- Design + words
- Filed
- 09 Dec 2020
- Published for opposition
- 06 Jul 2021
- Registered
- 21 Sept 2021
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
- Class 042 — Scientific and technological services: pharmaceutical research and development
- Class 044 — Medical, beauty and agricultural services: medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Owner
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
Prosecution history
- 21 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 06 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jul 2021 — PUBLISHED FOR OPPOSITION
- 16 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 May 2021 — ASSIGNED TO EXAMINER
- 16 Feb 2021 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 14 Feb 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Dec 2020 — NEW APPLICATION ENTERED